Pharma Mar, S.A.
PHMMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,782,445 | $1,359,067 | $1,409,963 | $1,381,016 |
| - Cash | $58,353 | $21,593 | $60,292 | $63,239 |
| + Debt | $59,057 | $51,400 | $51,940 | $51,075 |
| Enterprise Value | $1,783,149 | $1,388,874 | $1,401,611 | $1,368,852 |
| Revenue | $41,850 | $56,392 | $38,858 | $48,362 |
| % Growth | -25.8% | 45.1% | -19.7% | – |
| Gross Profit | $36,787 | $53,611 | $35,457 | $47,049 |
| % Margin | 87.9% | 95.1% | 91.2% | 97.3% |
| EBITDA | -$2,287 | $26,147 | -$1,099 | $15,203 |
| % Margin | -5.5% | 46.4% | -2.8% | 31.4% |
| Net Income | -$4,811 | $23,370 | -$3,949 | $18,684 |
| % Margin | -11.5% | 41.4% | -10.2% | 38.6% |
| EPS Diluted | -0.28 | 1.35 | -0.23 | 1.06 |
| % Growth | -120.7% | 687% | -121.7% | – |
| Operating Cash Flow | $19,576 | $9,149 | -$6,284 | $1,691 |
| Capital Expenditures | -$1,399 | -$1,421 | -$504 | -$1,897 |
| Free Cash Flow | $18,178 | $7,728 | -$6,788 | -$206 |